Scivanta Medical Corp (SCVM) financial statements (2020 and earlier)

Company profile

Business Address 215 MORRIS AVENUE
SPRING LAKE, NJ 07762
State of Incorp. DE
Fiscal Year End October 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

10/31/2015
10/31/2014
10/31/2013
10/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments22262064
Cash and cash equivalents22262064
Prepaid expense7712
Prepaid expense and other current assets10
Total current assets:29333274
Noncurrent Assets
TOTAL ASSETS:29333274
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities221163257313
Accounts payable102101216223
Accrued liabilities119624190
Debt695617305130
Due to related parties369212  
Other undisclosed current liabilities  97308
Total current liabilities:1,285992658751
Noncurrent Liabilities
Long-term debt and lease obligation105105205375
Long-term debt, excluding current maturities105105205375
Liabilities, other than long-term debt 105  
Due to related parties 105  
Other undisclosed noncurrent liabilities (105)  
Total noncurrent liabilities:105105205375
Total liabilities:1,3901,0978631,126
Stockholders' equity
Stockholders' equity attributable to parent(1,362)(1,065)(831)(1,052)
Common stock66531
Additional paid in capital23,08123,07122,88022,343
Accumulated deficit(24,449)(24,142)(23,717)(23,427)
Total stockholders' equity:(1,362)(1,065)(831)(1,052)
TOTAL LIABILITIES AND EQUITY:29333274

Income statement (P&L) ($ in thousands)

10/31/2015
10/31/2014
10/31/2013
10/31/2012
Cost of goods and services sold   (135)
Financial services costs (0) (1)
Gross profit: (0) (136)
Operating expenses(236)(426)(258)(254)
Other undisclosed operating income 81 136
Operating loss:(236)(346)(258)(254)
Nonoperating expense
(Other Nonoperating expense)
   (22)
Interest and debt expense(71)(79)(33)(27)
Net loss available to common stockholders, basic:(307)(424)(290)(303)
Interest on convertible debt(13)(29)  
Net loss available to common stockholders, diluted:(320)(453)(290)(303)

Comprehensive Income ($ in thousands)

10/31/2015
10/31/2014
10/31/2013
10/31/2012
Net loss:(307)(424)(290)(303)
Comprehensive loss, net of tax, attributable to parent:(307)(424)(290)(303)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: